Vaxzevria brought in a total of $3.9 billion in revenue in 2021. Read More

The WHO granted the vaccine an emergency use listing (EUL) in November 2021 but suspended the supply in April following its inspection of the Bharat Biotech facility. Read More

The Xpert Xpress CoV-2plus test is authorized for screening asymptomatic individuals. Read More

The WHO is recommending the vaccine for people age 18 years and older. Read More

The FDA has authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for children age five through 11 years. Read More

“The COVID-19 pandemic has changed the landscape for immune therapies, including the use of monoclonal antibodies to protect vulnerable patients who can’t respond adequately to vaccination alone,” said Iskra Reic, AstraZeneca’s executive vice president for vaccines and immune therapies. Read More

The FDA said it has received no reports of injuries, deaths, or adverse events associated with the recalled tests. Read More

Merck’s oral COVID treatment molnupiravir lacks adequate evidence to support claims that it’s any more effective than symptomatic care. Read More

The technologies are also made available through the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) program. Read More

The plant has produced more than 200 million doses of COVID-19 vaccines. Read More

In the wake of strongly positive data and an FDA go-ahead, Veru will seek an Emergency Use Authorization (EUA) for sabizabulin, its investigational COVID-19 therapy. Read More

Spikevax is not currently authorized or approved for children under 18. Read More